Despite an increasing number of reports, knowledge is still limited regarding risk factors and management strategies for respiratory virus infections. Therefore, the Infectious Diseases Working Party ...

Study met primary and secondary endpoints Paridiprubart demonstrated a relative reduction in the risk of death of 25% Treatment provided patients with clinically meaningful improvement in survival and ...